October 23, 2007 – After 12 months of the SPIRIT III trial, there were significantly fewer major adverse cardiac events (MACE) such as heart attacks, deaths from cardiac causes or repeat procedures (angioplasty or surgery) to clear the original vessel blockage after using a Xience V everolimus-eluting coronary stent than a Taxus paclitaxel-eluting stent, researchers reported at TCT 2007.

October 23, 2007 – Patients who received the CYPHER Sirolimus-eluting coronary stent had a lower risk of stent thrombosis and were less likely to need another procedure at the same lesion site (target lesion revascularization) than patients who received a Taxus stent, according to an analysis of 15-month data from the Western Denmark Heart Registry presented at TCT 2007.

October 23, 2007 - ENDEAVOR IV reached its primary endpoint of target vessel failure non-inferiority when compared to the Taxus stent, according to new 12-month data from Medtronic's ENDEAVOR IV (E-IV) trial presented at TCT 2007.
"It was very gratifying to learn that the Endeavor had similar efficacy compared to Taxus for all lesion subsets," said martin B. Leon, M.D., founder and chariman ermeritus of the Cardiovascular Research Foundation, professor of Medicine, Columbia University medical Center and principal investigator of the ENDEAVOR III and ENDEAVOR IV trials.

October 22, 2007 – At TCT 2007, ProSolv CardioVascular, a FUJIFILM company, (ProSolv) demonstrated its advanced quantification capabilities in a solution that integrates quantitative analysis software for cardiology and radiology with ProSolv’s industry-leading cardiovascular image and information system (CVIIS).

October 23, 2007 - Toshiba America Medical Systems Inc. today announced that the first U.S. installation of the Infinix CF-i/SP X-ray system was recently completed at Arlington Memorial Hospital, an acute-care full-service medical center, in Arlington, TX, reportedly allowing physicians a better ergonomic working environment for optimized patient care.

October 22, 2007 – A time-motion study conducted at Providence Heart Institute in Columbia, SC, spanning approximately 50 interventional coronary cases, found the Innova IVUS cuts procedure time by up to 40 percent, said GE Healthcare at TCT 2007.

OCTOBER 23, 2007 – Abbott’s fully bioabsorbable drug eluting stent platform for the treatment of coronary artery disease reported no stent thrombosis and a low major adverse cardiac event (MACE) rate at one year, according to results from ABSORB, the world’s first clinical trial evaluating the safety and performance of the stent, presented at TCT 2007.

October 22, 2007 - GE Healthcare highlighted the advantages of its digital flat panel Biplane imaging systems, the Innova 3131IQ and 2121IQ, which are designed to enable imaging fine vessels and cardiovascular anatomy and to perform 3D rotational imaging to produce three-dimensional images of the vascular system, bone and soft tissue in the body.

October 22, 2007 – Philips highlighted the integration of Volcano’s IVUS into its new Xper system and TrueView’s ability to import CT Angiography (CTA) exams into the cath lab.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now